ASP8825

DRUG5 trials

Sponsors

Astellas Pharma Inc

Conditions

Diabetic NeuropathiesHealthy VolunteersPatients With Impaired Renal Function and HaemodialysisRestless Legs Syndrome

Phase 1

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

CompletedNCT02629224

Astellas Pharma IncPatients With Impaired Renal Function and Haemodialysis

Start: 2008-02-29End: 2008-10-31Updated: 2016-02-04

ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825

CompletedNCT02632331

Astellas Pharma IncHealthy Volunteers

Start: 2009-01-31End: 2009-02-28Updated: 2015-12-16

Phase 2

ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy

TerminatedNCT00508430

Astellas Pharma IncDiabetic Neuropathies

Start: 2007-07-31End: 2008-11-30Updated: 2008-12-05

ASP8825 - Study in Patients With Restless Legs Syndrome

CompletedNCT00530530

Astellas Pharma IncRestless Legs Syndrome

Start: 2007-09-30End: 2009-01-31Updated: 2014-10-29

Phase 3

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

CompletedNCT02658188

Astellas Pharma IncRestless Legs Syndrome

Start: 2007-12-31End: 2009-04-30Updated: 2016-02-04

Related Papers

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.

2012-11-3028 citations